Haidi Wu

529 total citations
38 papers, 289 citations indexed

About

Haidi Wu is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Haidi Wu has authored 38 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 10 papers in Internal Medicine and 9 papers in Surgery. Recurrent topics in Haidi Wu's work include Venous Thromboembolism Diagnosis and Management (10 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). Haidi Wu is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (10 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). Haidi Wu collaborates with scholars based in China, United States and Hong Kong. Haidi Wu's co-authors include Rongwen Bian, Hongyan Cao, Qinglin Lou, Liting Zhou, Bai Xiao, Dongmei Chen, Shuo Yang, Shan Shan, Yun Yu and Bing Du and has published in prestigious journals such as Scientific Reports, British Journal Of Nutrition and Medicine.

In The Last Decade

Haidi Wu

33 papers receiving 284 citations

Peers

Haidi Wu

NEPHR

CCM

EDM

SURGE

EPIDE

Chao‐Hsiang Chang Taiwan

Jia Xia China

Blerim Mujaj Netherlands

Tsuyoshi Ueno Japan

Ahmet Uğur Yalçın Türkiye

Rebeccah Briskin United States

Ivano Baragetti Italy

Mark Radlinski United States

Guo Wei United States

Chao‐Hsiang Chang Taiwan

Haidi Wu

66 ×1.1

NEPHR

13 ×0.3

CCM

53 ×1.0

EDM

101 ×2.0

SURGE

40 ×0.9

EPIDE

Citations per year, relative to Haidi Wu Haidi Wu (= 1×) peers Chao‐Hsiang Chang

Countries citing papers authored by Haidi Wu

Since Specialization

Citations

This map shows the geographic impact of Haidi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haidi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haidi Wu more than expected).

Fields of papers citing papers by Haidi Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haidi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haidi Wu. The network helps show where Haidi Wu may publish in the future.

Co-authorship network of co-authors of Haidi Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Haidi Wu. A scholar is included among the top collaborators of Haidi Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haidi Wu. Haidi Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Fang, et al.. (2025). Healthcare providers’ perceptions of artificial intelligence in diabetes care: A cross-sectional study in China. International Journal of Nursing Sciences. 12(3). 218–224.

Wu, Haidi, et al.. (2024). The cardiovascular toxicity of polystyrene microplastics in rats: based on untargeted metabolomics analysis. Frontiers in Pharmacology. 15. 1336369–1336369. 20 indexed citations

Wu, Haidi, et al.. (2024). Association of serum uric acid to all-cause and cardiovascular mortality in patients with cardiovascular disease. Scientific Reports. 14(1). 21808–21808. 1 indexed citations

Wang, Zhenglin, et al.. (2023). Association of socioeconomic status with metabolic syndrome and its components among adult population: a community-based cross-sectional study in Nanjing Municipality of China. BMJ Open. 13(10). e074059–e074059. 5 indexed citations

Wu, Haidi, et al.. (2023). Effect of statin treatment on mortality in elderly patients with type 2 diabetes mellitus patients: a retrospective cohort study. BMC Geriatrics. 23(1). 549–549. 2 indexed citations

Zhang, Guilin, et al.. (2023). Meat, vegetable, and fruit consumption among urban and rural elders aged 60+ years in regional China: a population-level nutritional study. Journal of Nutritional Science. 12. e120–e120. 5 indexed citations

Wu, Haidi, et al.. (2023). The effects of brominated flame retardants (BFRs) on pro-atherosclerosis mechanisms. Ecotoxicology and Environmental Safety. 262. 115325–115325. 15 indexed citations

Wu, Haidi, et al.. (2023). Forecast of Steel Price on ARIMA-LSTM Model. 5 indexed citations

Cao, Hongyan, et al.. (2021). Higher than recommend dosage of sublingual isosorbide dinitrate for treating angina pectoris: a case report and review of the literature. Pan African Medical Journal. 39. 28–28. 1 indexed citations

10.

Wu, Haidi, et al.. (2020). Identification of foam cell biomarkers by microarray analysis. BMC Cardiovascular Disorders. 20(1). 211–211. 9 indexed citations

11.

Wu, Haidi, et al.. (2019). Considerations for routine coagulation monitoring with rivaroxaban: A case report and review of the literature. World Journal of Clinical Cases. 7(3). 382–388. 2 indexed citations

12.

Wu, Haidi, et al.. (2018). Routine coagulation test abnormalities caused by rivaroxaban. Medicine. 97(45). e13104–e13104. 4 indexed citations

13.

Wu, Haidi, et al.. (2018). Nephrotic syndrome with acute pulmonary embolism in young adults. Medicine. 97(29). e11495–e11495. 9 indexed citations

14.

Cao, Hongyan, et al.. (2017). LPA Gene Polymorphisms and Gene Expression Associated with Coronary Artery Disease. BioMed Research International. 2017. 1–6. 16 indexed citations

15.

Cao, Hongyan, et al.. (2016). A Case-Control Study of the Relationship Between SLC22A3-LPAL2-LPA Gene Cluster Polymorphism and Coronary Artery Disease in the Han Chinese Population. Iranian Red Crescent Medical Journal. 18(6). e35387–e35387.

16.

Shan, Shan, et al.. (2015). Evaluation of glycemic control in patients with type 2 diabetes mellitus in Chinese communities: a cross-sectional study. Clinical and Experimental Medicine. 17(1). 79–84. 19 indexed citations

17.

Ko, Gary T.C., et al.. (2015). Anthropometric parameters and their associations with cardio-metabolic risk in Chinese working population. Diabetology & Metabolic Syndrome. 7(1). 37–37. 12 indexed citations

18.

Wu, Haidi, et al.. (2013). Association of Genetic Polymorphisms in Matrix Metalloproteinase-9 and Coronary Artery Disease in the Chinese Han Population: A Case–Control Study. Genetic Testing and Molecular Biomarkers. 17(9). 707–712. 25 indexed citations

19.

Wu, Haidi. (2012). A systemic review of the efficacy and safety on comparison Tongxinluo capsule with Danshen tablet in the treatment of angina pectoris. 1 indexed citations

20.

Xu, Guoliang, et al.. (2012). The Efficacy and Safety of Cilnidipine on Mild to Moderate Essential Hypertension: A Systematic Review and Meta-analysis of Randomized Controlled Trials in Chinese Patients. Cardiovascular & Haematological Disorders - Drug Targets. 12(1). 56–62. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact